Hôpital national des 15-20

The 15-20 hospital is the reference in France and Europe for the management of all vision pathologies. It carries out the missions of a university hospital (care, teaching, research and prevention). Ranked among the best hospitals in France by Le Point magazine, it confirms its national positioning in ophthalmological surgery in the various fields assessed (1st in corneal, retina and glaucoma surgery).

Since 2018, the 15-20 hospital has been recognized with the Vision Institute as a University Hospital Institute: the IHU FOReSIGHT. The hospital is also a reference center for innovative therapies in the field of vision (world premiere in 2021 for optogenetic therapy, first European center to use ©Luxturna gene therapy).